| | 1165910-22-4 Basic information More.. |
| Product Name: | LGD-4033 | | Synonyms: | 4-((R)-2-((R)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoroMethyl)benzonitrile(LGD-4033);LGD-4033;4-[(2R)-2-[(1R)-2,2,2-Trifluoro-1-hydroxyethyl]-1-pyrrolidinyl]-2-(trifluoromethyl)benzonitrile;4-((R)-2-((R)-2,2,2-Trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoroMethyl)benzonitrile;LIGANDROL;4-[(2R)-2-[(1R)-2,2,2-trifluoro-1-hydroxyethyl]pyrrolidin-1-yl]-2-(trifluoromethyl)benzonitrile;LGD-4033 (Ligandrol);LGD-4033 whatsapp | | CAS: | 1165910-22-4 | | MF: | C14H12F6N2O | | MW: | 338.25 | | EINECS: | 1806241-263-5 | | Mol File: | 1165910-22-4.mol |  |
Use
LGD-4033 is a selective androgen receptor modulator (SARM). While it is currently being investigated as a pharmaceutical treatment for muscle wasting and weakness associated with aging, LGD-4033 has not been approved by the U.S. Food and Drug Administration (FDA) for clinical use in humans.
- LGD-4033
-
- US $90.00-80.00 / kg
- 2024-04-26
- CAS:1165910-22-4
- Min. Order: 0.10000000149011612kg
- Purity: min99%
- Supply Ability: 100 tons
- Ligandrol
-
- US $20.00-100.00 / g
- 2024-04-26
- CAS:1165910-22-4
- Min. Order: 10g
- Purity: 99.9%
- Supply Ability: 1000kg
|
|
1165910-22-4
Recommend Suppliers |
|